ClearPoint Neuro, Inc.
US ˙ NasdaqCM ˙ US18507C1036

Introduction

This page provides a comprehensive analysis of the known insider trading history of Richards Timothy T.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Richards Timothy T. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CLPT / ClearPoint Neuro, Inc. Director 78,315
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Richards Timothy T.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CLPT / ClearPoint Neuro, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLPT / ClearPoint Neuro, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2015-12-18 MRIC Richards Timothy T. 77,017 77,017 731

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Sales CLPT / ClearPoint Neuro, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLPT / ClearPoint Neuro, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-06-10 CLPT Richards Timothy T. 10,000 13.2800 10,000 13.2800 132,800 52 10.0000 -32,800 -24.70

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Richards Timothy T. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-02 2025-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 934 78,315 1.21 11.94 11,152 935,081
2025-06-12 2025-06-10 4 CLPT ClearPoint Neuro, Inc.
Common Stock
S - Sale -10,000 77,381 -11.44 13.28 -132,800 1,027,620
2025-05-19 2025-05-16 4 CLPT ClearPoint Neuro, Inc.
Common Stock
M - Exercise 21,093 87,381 31.82
2025-04-02 2025-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 938 66,288 1.44 11.89 11,153 788,164
2025-01-03 2025-01-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 725 65,350 1.12 15.38 11,150 1,005,083
2024-10-02 2024-10-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 995 64,625 1.56 11.21 11,154 724,446
2024-07-02 2024-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,069 63,630 3.36 5.39 11,152 342,966
2024-05-15 2024-05-14 4 CLPT ClearPoint Neuro, Inc.
Common Stock
M - Exercise 17,153 61,561 38.63
2024-04-02 2024-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,640 44,408 3.83 6.80 11,152 301,974
2024-01-03 2024-01-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,643 42,768 4.00 6.79 11,156 290,395
2023-10-03 2023-10-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,226 41,125 5.72 5.01 11,152 206,036
2023-07-05 2023-07-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,540 38,899 4.12 7.24 11,150 281,629
2023-04-04 2023-04-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,321 37,359 3.67 8.44 11,149 315,310
2023-01-04 2023-01-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,399 36,038 4.04 7.97 11,150 287,223
2022-10-04 2022-10-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,094 34,639 3.26 10.19 11,148 352,971
2022-07-06 2022-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 883 33,545 2.70 12.63 11,152 423,673
2022-05-27 2022-05-25 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 6,179 6,179
2022-05-27 2022-05-25 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 9,269 32,662 39.62
2022-04-05 2022-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,120 23,393 5.03 9.96 11,155 232,994
2022-01-04 2022-01-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 644 22,273 2.98 11.54 7,432 257,030
2021-10-04 2021-10-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 414 21,629 1.95 17.92 7,419 387,592
2021-07-02 2021-06-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 291 21,215 1.39 20.26 5,896 429,816
2021-06-28 2021-06-25 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 6,006 6,006
2021-06-28 2021-06-25 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 3,003 20,924 16.76
2021-04-02 2021-03-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 306 17,921 1.74 19.57 5,988 350,714
2021-01-04 2020-12-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 399 17,615 2.32 15.00 5,985 264,225
2020-10-01 2020-09-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,051 17,216 6.50 5.71 6,001 98,303
2020-07-02 2020-06-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,687 16,165 11.65 3.55 5,989 57,386
2020-06-17 2020-06-03 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 15,000 15,000
2020-04-02 2020-03-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,680 14,478 13.13 3.57 5,998 51,686
2020-01-02 2019-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 605 12,798 4.96 4.96 3,001 63,478
2019-10-01 2019-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 582 12,193 5.01 5.15 2,997 62,794
2019-07-01 2019-06-28 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 947 11,611 8.88 3.17 3,002 36,807
2019-06-10 2019-06-07 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 15,000 15,000
2019-04-02 2019-03-29 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 953 10,664 9.81 3.15 3,002 33,592
2019-01-02 2018-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 2,040 9,711 26.59 1.47 2,999 14,275
2018-10-01 2018-09-28 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 1,707 7,671 28.62 1.76 3,004 13,501
2018-07-03 2018-06-29 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 1,377 5,964 30.02 2.18 3,002 13,002
2018-06-11 2018-06-08 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 15,000 15,000
2018-04-02 2018-03-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 958 4,587 26.40 3.13 2,999 14,357
2017-12-14 2017-12-12 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 15,000 15,000
2016-06-09 2016-06-08 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2016-04-01 2016-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 18,694 145,162 14.78 0.31 5,795 45,000
2016-01-04 2015-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 16,463 126,468 14.97 0.38 6,256 48,058
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Series B Warrants (right to buy)
P - Purchase 23,106 23,106
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Series A Warrants (right to buy)
P - Purchase 30,807 30,807
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
P - Purchase 77,017 110,005 233.47
2015-10-02 2015-10-01 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 9,585 32,988 40.96 0.60 5,751 19,793
2015-07-02 2015-06-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 5,337 23,403 29.54 1.08 5,764 25,275
2015-06-09 2015-06-05 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2015-04-02 2015-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 6,250 18,066 52.89 1.00 6,250 18,066
2015-01-05 2014-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 4,833 11,816 69.21 0.86 4,166 10,185
2014-10-02 2014-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 3,387 6,983 94.19 1.23 4,166 8,589
2014-07-02 2014-06-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 3,104 3,596 630.89 1.02 3,166 3,668
2014-06-05 2014-06-04 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2014-04-02 2014-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 492 492 1.24 610 610
2014-03-10 2014-03-10 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 45,000 45,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)